SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-000935
Filing Date
2022-01-11
Accepted
2022-01-11 16:05:27
Documents
23
Period of Report
2022-01-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 71792
2 ex1-1.htm EX-1.1 59000
3 ex3-1.htm EX-3.1 137713
4 ex3-2.htm EX-3.2 137328
5 ex5-1.htm EX-5.1 14906
6 ex5-1_001.jpg GRAPHIC 5204
7 ex5-1_002.jpg GRAPHIC 8636
8 ex5-2.htm EX-5.2 11106
9 ex5-2_001.jpg GRAPHIC 5204
10 ex5-2_002.jpg GRAPHIC 8636
11 ex10-1.htm EX-10.1 250591
12 ex99-1.htm EX-99.1 17026
  Complete submission text file 0001493152-22-000935.txt   1053105

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE clsn-20220110.xsd EX-101.SCH 3030
14 XBRL LABEL FILE clsn-20220110_lab.xml EX-101.LAB 34476
15 XBRL PRESENTATION FILE clsn-20220110_pre.xml EX-101.PRE 22593
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3721
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Celsion CORP (Filer) CIK: 0000749647 (see all company filings)

IRS No.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15911 | Film No.: 22523921
SIC: 2834 Pharmaceutical Preparations